[Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages].

The purified preparations of Klebsiella bacteriophages, viz. the monovalent preparation of K. pneumoniae bacteriophage and the polyvalent bacteriophage preparation for the treatment of infections caused by K.

[Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms].

The authors assess the efficacy of phage therapy ofsuppurative and inflammatory complications in oncological patients. A clinical and laboratory analysis has involved 131 patients whose etiotropic therapy consisted of bacteriophages (65 patients) and antibiotics (66). Medicinal phages, manufactured by the Tbilisi Research Institute for Vaccines and Sera, have been administered according to 3 schemes: (1) parallel with antibiotics, (2) after long ineffective antibiotic therapy, (3) phages alone starting from the onset of the purulent complication.

[Klebsiella infection in oncological patients and K-serovars isolated with this causative agent].

The biochemical identification and serological typing of 104 Klebsiella pneumoniae strains isolated from oncological patients in cases of purulent septic complications were carried out with the use of agglutinating K-sera prepared at the All-Union Escherichia Center. According to the character of K-antigens contained in these strains they were found to belong to 27 serovars. 6 strains proved to be in the R-form, and the typing of 7 strains could not be carried out with the set of sera used in this investigation.